. Author manuscript; available in PMC: 2014 Aug 1.

Published in final edited form as: Clin Transl Sci. 2013 Jun 10;6(4):279–285. doi: 10.1111/cts.12073

Table 1.

Eligibility data for contracts negotiated at participating CTSA sites.

Eligibility Criteria
Assigned to a negotiator between October 1, 2009 and November 30, 2009. The first 25 Industry-sponsored contracts assigned to a negotiator The first 10 Investigator Initiated contracts assigned to a negotiator. Industry sponsor or Investigator sponsor with industry support or a CRO contracted by industry Related Clinical trial/study, financed by industry without other external support No required contract, subcontract, or award from a third-party for support, services, pharmaceuticals, or other materials The product being evaluated is a drug, biologic treatment, vaccine, or device.

Eligibility Criteria

Assigned to a negotiator between October 1, 2009 and November 30, 2009.
The first 25 Industry-sponsored contracts assigned to a negotiator
The first 10 Investigator Initiated contracts assigned to a negotiator.
Industry sponsor or Investigator sponsor with industry support or a CRO contracted by industry
Related Clinical trial/study, financed by industry without other external support
No required contract, subcontract, or award from a third-party for support, services, pharmaceuticals, or other materials
The product being evaluated is a drug, biologic treatment, vaccine, or device.